CreditReports.dk
HomeScreen companies

LIPLASOME PHARMA ApS Financials, key figures and credit report

CVR number: 29428514 Established 2006 Industry: 72 Scientific research and development
Company contact details
Tabletvej 1, 7100 Vejle tel: 49288888
Gross profit -28.0 kDKK FY 2025 +47.2% vs 2024
EBIT -28.0 kDKK FY 2025 +47.2% vs 2024
Net debt - 302.0 kDKK FY 2025 +4.7% vs 2024
Quick ratio 199.1 FY 2025 +43.8 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit108.002 202.00-29.00-53.00-28.00
EBIT108.002 202.00-29.00-53.00-28.00
Other financial income9.004.004.008.0091.00
Other financial expenses-19.00-10.00-1.00-1.00-1.00
Pre-tax profit98.002 196.00-26.00-46.0062.00
Income taxes6.0010.00
Net earnings98.002 196.00-20.00-36.0062.00

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors39.0062.00252.00
Current amounts owed by group member comp.2 000.002 000.002 087.00
Current other receivables2.003.00
Current deferred tax assets44.006.0010.00
Short term receivables total85.0062.002 258.002 013.002 087.00
Cash and bank deposits102.002 321.00105.00317.00302.00
Cash and cash equivalents102.002 321.00105.00317.00302.00
Balance sheet total (assets)187.002 383.002 363.002 330.002 389.00

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital92.0092.0092.0092.0092.00
Retained earnings-15.0083.002 279.002 259.002 223.00
Profit of the financial year98.002 196.00-20.00-36.0062.00
Shareholders equity total175.002 371.002 351.002 315.002 377.00
Non-current liabilities total
Current trade creditors12.0011.0012.0015.0012.00
Other non-interest bearing current liabilities1.00
Current liabilities total12.0012.0012.0015.0012.00
Balance sheet total (liabilities)187.002 383.002 363.002 330.002 389.00
Page generated